Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Shmuel Chen

Interventional Cardiology New York, NY Medical Doctor

NPI 1841757606 CMS profile 8080232

525 E 68Th St, New York, NY 10065

Open in the dashboard

General payments

$37,793

329 records reported · program years 2020–2025

Research payments

$2,000

Paid to them · 1 record reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$184,864 paid to institutions, not to them · program year 2025

Through program year 2025, Shmuel Chen of New York, NY is reported in the CMS Open Payments database as having received $37,793 across 329 general payments and $2,000 in research payments paid to them. Separately, studies naming them as principal investigator received $184,864 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 84th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,984 56
2024 General $10,854 124
2024 Research $2,000 1
2023 General $6,387 77
2022 General $4,236 47
2021 General $2,054 19
2020 General $279 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shmuel Chen
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Shmuel Chen were reported at $13,984. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Shmuel Chen Interventional Cardiology median Middle half National median
2019 $0 $1,097 $329–$3,048 $163
2020 $279 $473 $161–$1,480 $114
2021 $2,054 $677 $233–$1,827 $132
2022 $4,236 $978 $333–$2,724 $149
2023 $6,387 $1,136 $382–$2,986 $160
2024 $10,854 $1,181 $395–$3,326 $164
2025 $13,984 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medtronic, Inc. $13,956 107 payments
  2. Edwards Lifesciences Corporation $10,149 97 payments
  3. Abbott Laboratories $6,603 80 payments
  4. Ancora Heart, Inc. $2,441 7 payments
  5. Boston Scientific Corporation $1,399 15 payments
  6. Philips Electronics North America Corporation $961 3 payments
  7. Cardiovascular Systems Inc. $812 7 payments
  8. Shockwave Medical, Inc $390 2 payments
  9. AstraZeneca Pharmaceuticals LP $277 3 payments
  10. SpectraWAVE, Inc $244 2 payments
  11. Other $561 6 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $17,865 284 payments
  2. Travel and Lodging $13,684 43 payments
  3. Consulting Fee $5,963 1 payment
  4. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2020–2025
  1. COREVALVE EVOLUT R $13,459 104 payments
  2. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $4,158 2 payments
  3. AccuCinch $2,441 7 payments
  4. AMPLATZER AMULET $1,466 11 payments
  5. NAVITOR $1,022 15 payments
  6. (9525) Intracardiac Und $961 3 payments
  7. SAPIEN 3 Ultra RESILIA $879 29 payments
  8. MITRACLIP $864 19 payments
  9. Diamondback Coronary $600 5 payments
  10. PASCAL $555 9 payments
  11. Other $5,847 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2020–2025
  1. Medtronic, Inc. $2,000 1 payment

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$192,194

Medicare's payments for the services billed

Medicare patients

396

Average age 78

Services billed

1,144

182 women, 214 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 71%
Arthritis 54%
Chronic kidney disease 47%
Diabetes 44%
Atrial fibrillation 44%
COPD 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

330 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record